J07CA Bacterial and viral vaccines, combined

Place in the ATC classification

1. J Antiinfectives for systemic use 1,393 medicines
   1. J07 Vaccines 124 medicines
      1. J07C Bacterial and viral vaccines, combined 16 medicines
         1. J07CA Bacterial and viral vaccines, combined 16 medicines
            1. J07CA01 diphtheria-poliomyelitis-tetanus 1 medicine
            2. J07CA02 diphtheria-pertussis-poliomyelitis-tetanus 2 medicines
            3. J07CA05 diphtheria-hepatitis B-pertussis-tetanus 1 medicine
            4. J07CA06 diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus 1 medicine
            5. J07CA09 diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B 7 medicines
            6. J07CA10 typhoid-hepatitis A 1 medicine
            7. J07CA12 diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B 1 medicine

6 more subgroups have no medicine with a leaflet on this site.

Active substances in the group

• Diphtheria toxoid, hepatitis B surface antigen, Bordetella pertussis (inactivated), tetanus toxoid 1 medicine
• Diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin), hepatitis B surface antigen, poliovirus (inactivated) (type-1 (Mahoney strain), type-2 (MEF-1 strain), type-3 (Saukett strain)), 1 medicine
• Diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin), poliovirus (inactivated) (type 1 (Mahoney strain), type 2 (MEF-1 strain), type 3 (Saukett strain)), hepatitis B surface antigen 1 medicine
• Diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens: pertussis toxoid, filamentous haemagglutinin, pertactin, fimbriae Types 2 and 3, hepatitis B surface antigen produced in yeast cells, poliovirus (inactivated): type 1 (Mahoney), type 2 … 1 medicine
• Diphtheria toxoid, tetanus toxoid, inactivated Bordetella pertussis, hepatitis B surface antigen (rDNA), Haemophilus influenzae type b polysaccharide 1 medicine
• Filamentous haemagglutinin, Haemophilus influenzae type B polysaccharide (polyribosylribitol phosphate), hepatitis B surface antigen, pertussis toxoid, poliovirus (inactivated) type 1 (Mahoney strain) produced on Vero cells, poliovirus (inactivated) type 1 medicine
• Hepatitis B surface antigen, Diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens Pertussis Toxoid Filamentous Haemagglutinin, poliovirus (inactivated) type 1 (Mahoney) type 2 (MEF-1) type 3 (Saukett), Haemophilus influenzae type b 1 medicine
• Polyribosylribitol phosphate from Haemophilus influenzae type b as PRP-OMPC, outer membrane protein complex of Neisseria meningitidis (outer membrane protein complex of the B11 strain of Neisseria meningitidis subgroup B), adsorbed hepatitis B surface 1 medicine
• Purified diphtheria toxoid, Purified Tetanus Toxoid, purified pertussis toxoid, purified pertussis filamentous haemagglutinin, hepatitis B surface antigen, Inactivated Type 1 Poliovirus (Mahoney), inactivated type 2 poliovirus (MEF 1), Inactivated Type 3 1 medicine
• Tetanus toxoid 2 medicines

Medicines in the group and its subgroups

Other names of the ATC group

• Czech: J07CA Bakteriální a virové vakcíny, kombinované
• French: J07CA vaccins bactériens et viraux associés
• German: J07CA Bakterielle und virale Impfstoffe, kombiniert
• German: J07CA Bakterielle und virale Impfstoffe, kombiniert
• Italian: J07CA VACCINI BATTERICI E VIRALI IN ASSOCIAZIONE
• Polish: J07CA Szczepionki bakteryjne i wirusowe połączone
• Turkish: J07CA Bakteriyel ve viral aşılar, kombine
• Portuguese (Brazil): J07CA Vacinas bacterianas e víricas associadas